Treatment of glaucoma with drug-loaded contact lenses: A systematic review and meta-analysis

Diya Zhang1, Cong Ren2, Xuan Wang1

  • 1Shandong University of Traditional Chinese Medicine, Jinan, 250355, China.

PubMed
Abstract

Insights

Drug-loaded contact lenses offer effective and safe glaucoma treatment, significantly reducing intraocular pressure (IOP) compared to eye drops. Nanoparticle formulations with timolol are recommended for future clinical research.

Area of Science:

  • Ophthalmology
  • Materials Science
  • Pharmacology

Background:

  • Glaucoma treatment traditionally relies on eye drops, which can have compliance issues and side effects.
  • Drug-loaded contact lenses offer a novel sustained-release drug delivery system for managing intraocular pressure (IOP).

Purpose of the Study:

  • To systematically review the effectiveness and safety of drug-loaded contact lenses for glaucoma treatment.
  • To provide guidance for future clinical research in this area.

Main Methods:

  • A systematic literature search was conducted up to May 1, 2024, across multiple databases.
  • Included studies were assessed for quality using CAMARADES.
  • Safety, intraocular pressure reduction (IOPR), and duration of IOP decline were analyzed qualitatively and quantitatively.

Main Results:

  • 47 studies were included, showing significant IOP reduction (up to 50%) and no corneal damage in clinical trials.
  • Medicated contact lenses demonstrated superior IOP reduction compared to eye drops in animal models.
  • Contact lenses with timolol, timolol + dorzolamide, and timolol + latanoprost showed better IOP reduction; puerarin, latanoprost, and timolol + bimatoprost did not.
  • Sustained drug release and IOP reduction for at least 3 days were observed.

Conclusions:

  • Drug-loaded contact lenses demonstrate excellent efficacy and safety for glaucoma management.
  • Nanoparticle-loaded contact lenses containing timolol are a promising option for future clinical investigation.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
384
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
429
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
495
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
302